Piribo: Financial Markets Research: ASCO Review Part IICO 2006 Annual Meeting, new publication announcement

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report called “Financial Markets Research: ASCO Review Part IICO 2006 Annual Meeting - A summary of highlights presented at the ASCO 2006 Annual Meeting”. http://www.piribo.com/publications/finance_investment/financial_markets_research_asco_review_part_iico_2006_annual_meeting.html

ASCO features key presentations in the oncology area, and is generally the most important week of the year for oncology. Presents Datamonitor's comments on the most important events at the 2006 conference.

Highlights
GlaxoSmithKline's lapatinib should represent a new standard of care for patients for HER2+ metastatic breast cancer patients that have progressed after Herceptin. Furthermore, the strength of lapatinib in a post-Herceptin setting supports the development of this drug in earlier settings.Following dasatinib's favorable review by an FDA panel, we believe data presented at ASCO is likely to have a very positive impact on the rate of uptake of dasatinib.Advantage in the renal cell carcinoma market has shifted to PFE's Sutent after data comparing BAY/ONXX's Nexavar to interferon in the front-line setting was not ready to be presented, thus opening the door for Sutent.

Scope
- Provides a summary of highlights presented at ASCO 2006 on Friday June 2, 2006 through Sunday June 4, 2006
- Drugs covered include Amgen's denosumab (AMG-162), AstraZeneca's Zactima (vandetanib/ZD6474), and Bristol-Myers Squibb's Sprycel (dasatinib)
Reasons to Purchase
- Identify the most important events that occurred at ASCO 2006
- Understand the impact of key data presentations on the potential future dynamics of the oncology market

Contents
Summary
Asco Coverage
Highlights In Renal Cell Carcinoma
Highlights In Multiple Myeloma
Appendix

“Financial Markets Research: ASCO Review Part IICO 2006 Annual Meeting - A summary of highlights presented at the ASCO 2006 Annual Meeting” is available from Piribo. For more information go to: http://www.piribo.com/publications/finance_investment/financial_markets_research_asco_review_part_iico_2006_annual_meeting.html

Piribo Product ID: DAT543

About Piribo.
Piribo (http://www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,800 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.